From: Indigenous populations health protection: A Canadian perspective
Topics | Type of disease | Research methods | Recommendations |
---|---|---|---|
Vaccines | Helicobacter pylori, Haemophilus influenzae | Laboratory, surveillance, and modelling | Develop new vaccine candidates for helicobacter pylori and haemophilus influenza A |
Antiviral drugs | Influenza viruses with pandemic potential | Modelling and simulations | Evaluate antiviral strategies for emerging influenza viruses in remote and isolated communities. Create formal structures for strategy development with oversight bodies and multi-stakeholder networks |
Healthcare access, program development, and delivery | Infectious diseases (influenza, haemophilus influenzae, helicobacter pylori, tuberculosis, sexually transmitted diseases) | Population health surveillance, modelling and simulations | Enhance collaborative multi-jurisdictional efforts. Involve indigenous communities in the development of healthcare programs and delivery. Deploy more resources (e.g., medical equipment and pharmaceutical measures) to remote regions and improve training of healthcare professionals. Streamline public health surveillance systems across Canada to build more comprehensive databases |
Determinants of health | Chronic diseases (cancer, cardiovascular diseases, diabetes); Chronic mental health illnesses (schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorders) | Population health surveys, clinical investigations, community engagement, and focus group discussions | Develop educational programs to eliminate cross-cultural barriers (e.g., language training). Review and evaluate the impact of public health decisions on health inequalities. Develop policies and programs to address homelessness beyond responses to emerging crises |